Before lung cancer develops, precancerous lesions are found in the airway, but only some of these will actually become lung cancer, while others will disappear or remain benign without becoming harmful. Under the microscope, the lesions look the same, making it difficult to know which lesions to treat. A new…...
Antibodies to a retina protein to be used as a kidney cancer marker
Tumors can be benign or malignant. Benign tumors can evolve into malignant ones. Around 90 to 93% of all kidney growths turn out to be malignant, and there are currently no effective methods for early diagnostics. The initial stages of kidney cancer have no signs or specific symptoms, so patients are often…...
Making Progress
This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the Global Coalition for Adaptive Research (GCAR), the non-profit…...
What happens if chemotherapy does not work?
Chemotherapy is used by doctors to either as a first-line therapy or in combination with other treatments, such as surgery, to treat cancer. If chemotherapy does not work, a person may need to consider other treatment options. Signs that the cancer is not responding to chemotherapy include the growing or spreading…...
DNA origami: A precise measuring tool for optimal antibody effectiveness
Using DNA-based designs of precise nanostructures — scientists have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system. The study may be of significance to the development of vaccines and immunotherapy used in cancer.…...
A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors
In the United States, it is estimated that more than 1.7 million people will be diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial costs associated with cancer risk factors and cancer care are enormous. To substantially reduce both the number of individuals…...
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new…...
Hong Kong Cancer Day-A Look Back
The Asian Fund for Cancer Research was proud to have been among the 50-plus organizations and companies to have participated in the Hong Kong Anti-Cancer Society’s Hong Kong Cancer Day activities, held Sunday, 2018-12-9, at the Piazza of Kowloon Park in Tsim Sha Tsui. A full slate of family-friendly programming,…...
Hong Kong Cancer Day
On 2018-12-09, the Asian Fund for Cancer Research will be supporting and participating in the Hong Kong Anti-Cancer Society’s full day of Hong Kong Cancer Day programming. Actress Sonija Kwok will be serving as event ambassador, and among the special guests will be Hong Kong Secretary of Food and Health…...
